Treatment
Cerebrolysin clinical trials
We’re tracking 5 recruiting studies that include Cerebrolysin, each written for real people, not researchers, below.
Recruiting studies
- NCT07043686Recruiting
Cerebrolysin for early stroke recovery
This trial tests if adding Cerebrolysin to standard rehabilitation helps people recover arm and hand function better after a first-time, moderate stroke. You may be eligible if you had a stroke and can follow simple instructions.
LjubljanaAges 18 years+ - NCT04427241RecruitingPhase 4
Testing Cerebrolysin for prolonged brain injury after bleeding stroke
This study tests whether Cerebrolysin can improve recovery in people who remain in a vegetative or minimally conscious state more than 4 weeks after a bleeding stroke. It also tracks safety, to make sure the treatment is not causing harmful side effects.
SeoulAges 19–120 - NCT05821075RecruitingPhase 1/Phase 2
Prednisolone vs Cerebrolysin for sudden facial weakness
This early-stage study compares two medicines—prednisolone and cerebrolysin—to see which works better for Bell’s palsy (sudden one-sided facial weakness with no clear cause). You may be asked to take one of the study treatments and be followed to measure how well facial movement improves.
GizaAges 18–60 - NCT06677502Enrolling by invitation
Cerebrolysin for delirium in ICU patients
This trial tests a medicine called Cerebrolysin to see if it helps reduce confusion and agitation (delirium) in patients who are critically ill and being treated in the ICU. It may be an option for you if you are over 18 and have delirium symptoms.
Lubin, Lublin VoivodeshipAges 18–100 - NCT06897176RecruitingPhase 4
Cerebrolysin for speech recovery after stroke
This study tests whether a medicine called Cerebrolysin can help improve speech in people who have trouble speaking after a stroke. It is for Korean speakers who had their first stroke within the last month.
SeoulAges 19–90
What Cerebrolysin is being studied for
Conditions with recruiting Cerebrolysin studies.
Common questions
- Are there clinical trials studying Cerebrolysin?
- Yes. Clin2 currently lists 5 recruiting studies that include Cerebrolysin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Cerebrolysin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Cerebrolysin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Cerebrolysin or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.